Komori
Terumo (4543) · PolicyAdvanced

Managing Business Performance Using Adjusted Operating Profit

First written in FY2023-Q1. 7 of 13 entries say "Advanced", first in FY2024. Latest entry: 2026-08-07.

13entries
5years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2023-Q1 – FY2024-Q3AdvancedFY2024 – 2026-08-072022: 220222023: 320232024: 320242025: 220252026: 32026
Same theme, other companies
Measuring Underlying Performance through Adjusted Operating ProfitA theme 19 companies write about · 0 as a headwind · 16 as a tailwind

5 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 19 companies compared. The sentences above are computed from all 19.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-07AdvancedEarnings

    「Adjusted operating profit increased 34.7% year on year to ¥79.6 billion, owing to higher gross profit.」

    The Company continued to use adjusted operating profit as a performance management metric, with first-quarter adjusted operating profit increasing 34.7% year on year.
  2. FY2026AdvancedAnnual report

    「Adjusted operating profit increased 7.8% from the previous fiscal year to ¥219.4 billion, mainly due to higher gross profit and other factors.」

    Adjusted operating profit used to manage the performance of each business was ¥219.369 billion, up 7.8% from the previous fiscal year. The company also newly disclosed segment profit of ¥1,665 million for the Organ Technologies business.
  3. 2026-05-15AdvancedEarnings

    「Adjusted operating profit is a metric used in management to understand the performance of each business as the Terumo Group seeks sustainable medium- to long-term growth, and we believe it also provides useful information for users of the financial statements in evaluating the performance of the Terumo Group.」

    The Company reaffirmed the positioning of adjusted operating profit as a performance management metric and disclosed current-year results of ¥219,369 million and a forecast of ¥261,500 million for the next fiscal year.
  4. FY2026-H1AdvancedAnnual report

    「Adjusted operating profit increased 10.0% year on year to ¥114.4 billion, mainly due to higher gross profit and other factors. The Group also discloses adjusted operating profit as an additional performance management metric, which is not defined under IFRS, the accounting standards applied by the Group. Adjusted operating profit is profit adjusted for amortization of intangible assets acquired in connection with acquisitions and one-off gains and losses, and is equivalent to segment profit.」

    The company continues to use adjusted operating profit as a performance management metric for each business. FY2026-H1 adjusted operating profit increased 10.0% year on year to ¥114.4 billion.
  5. FY2025AdvancedAnnual report

    「Adjusted operating profit increased 29.8% from the previous fiscal year to ¥203.4 billion, mainly due to higher gross profit and other factors.」

    The company continues to use adjusted operating profit as a performance management metric for each business. FY2025 adjusted operating profit was ¥203.4 billion, up 29.8% from the previous fiscal year.
  6. FY2025-H1AdvancedAnnual report

    「Adjusted operating profit increased 37.6% year on year to ¥104.0 billion, mainly due to higher gross profit.」

    Adjusted operating profit used to manage the performance of each business increased 37.6% year on year to ¥104.0 billion.
  7. FY2024AdvancedAnnual report

    「Adjusted operating profit increased 13.6% from the previous fiscal year to ¥156.8 billion, mainly due to higher gross profit. The Group also discloses adjusted operating profit as an additional performance management metric. Adjusted operating profit is profit adjusted for amortization of intangible assets acquired in connection with acquisitions and one-off gains and losses, and is equivalent to segment profit.」

    The company continues to use adjusted operating profit as a management metric for each business, with FY2024 adjusted operating profit increasing 13.6% from the previous fiscal year to ¥156.8 billion.
  8. FY2024-Q3RestatedAnnual report

    「Adjusted operating profit is a metric used in management to understand the performance of each business as the Terumo Group seeks sustainable medium- to long-term growth, and we believe it also provides useful information for users of the financial statements in evaluating the performance of the Terumo Group.」

    The company continues to use and disclose adjusted operating profit as a management metric for assessing the performance of each business. Adjusted operating profit for the first 3 quarters was ¥119.733 billion, up 9.2% year on year.
  9. FY2024-Q2RestatedAnnual report

    「Adjusted operating profit is a metric used in management to understand the performance of each business as the Terumo Group seeks sustainable medium- to long-term growth, and we believe it also provides useful information for users of the financial statements in evaluating the performance of the Terumo Group.」

    The company continues to use and disclose adjusted operating profit as a management metric for assessing the performance of each business. Adjusted operating profit for the first 2 quarters was ¥75.6 billion, up 7.3% year on year.
  10. FY2024-Q1RestatedAnnual report

    「Adjusted operating profit is a metric used in management to understand the performance of each business as the Terumo Group seeks sustainable medium- to long-term growth, and we believe it also provides useful information for users of the financial statements in evaluating the performance of the Terumo Group.」

    The company continues to use and disclose adjusted operating profit as a management metric for assessing the performance of each business. Adjusted operating profit in FY2024-Q1 decreased 3.9% year on year.
  11. FY2023-Q3RestatedAnnual report

    「Adjusted operating profit is a metric used in management to understand the performance of each business as the Terumo Group seeks sustainable medium- to long-term growth, and we believe it also provides useful information for users of the financial statements in evaluating the performance of the Terumo Group.」

    The company continues to use and disclose adjusted operating profit as a performance management metric for each business, adjusted for amortization of acquisition-related intangible assets and one-off gains and losses.
  12. FY2023-Q2RestatedAnnual report

    「Adjusted operating profit is a metric used in management to understand the performance of each business as the Terumo Group seeks sustainable medium- to long-term growth, and we believe it also provides useful information for users of the financial statements in evaluating the performance of the Terumo Group.」

    The company continues to use and disclose adjusted operating profit as a performance management metric for each business, adjusted for amortization of acquisition-related intangible assets and one-off gains and losses.
  13. FY2023-Q1First statedAnnual report

    「Adjusted operating profit is a metric used in management to understand the performance of each business as the Terumo Group seeks sustainable medium- to long-term growth, and we believe it also provides useful information for users of the financial statements in evaluating the performance of the Terumo Group.」

    The company specified its policy of using adjusted operating profit to evaluate and manage each business as a performance management metric adjusted for amortization of acquisition-related intangible assets and one-off gains and losses.
Moved together

"Expanding market share in global markets and enhancing brand value" moved the same way as this thread, in the same document, in 7 of its 13 moves.

766666★123456
  1. ★This thread
  2. 1Expanding market share in global markets and enhancing brand value7×
  3. 2Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets6×
  4. 3Becoming a Company with a Strong Global Presence and Achieving Sustainable, Profitable, High-Quality Growth6×
  5. 4Global sales expansion of cardiovascular products such as Ultimaster6×
  6. 5Strengthening Cost Competitiveness Through Products Tailored to Regional Needs and a Global Production Network6×
  7. 6Consistent Dividend Growth and a Medium- to Long-Term Payout Ratio of 30%6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Terumo yet. It last moved in the Earnings of 2026-08-07: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Managing Business Performance Using Adjusted Operating Profit | TERUMO CORPORATION (4543) | Komori